Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
The Analysis of Isotopically Labeled
Propylene Glycol in eCigarettes
Raymond H. Farmen, Ph.D.
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
The Coolest eCigarette Clinical Study Using
Isotopically Labeled Propylene Glycol
Raymond H. Farmen, Ph.D.
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Presentation flow
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Celerion’s Patent for Testing e-Cigarettes
E-Cigarettes vaporize liquid nicotine in solvent
(propylene glycol or glycerol)
Problem: Solvents used are ubiquitous. Need to distinguish how much of this constituent get into the blood from the e-Cig, rather than the environment.
Patented Solution: Replace the solvent with a solvent that was made with stable isotopes (mass is greater)!! Use mass spectrometry to distinguish between endogenous levels of the constituents and those that came from the e-Cig
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
5
Chemistry 101
- Stable Isotopes
> 99.99% of hydrogen on earth has an AMU = 1.
> 99.9% of carbon on earth has an AMU = 12.
An isotope of an atom has an atypical AMU.
* stable isotope
** unstable isotope = radioactive
Atom Identification # Protons # Neutrons AMU
Hydrogen Hydrogen 1 0 1
Deuterium* 1 1 2
Tritium** 1 2 3
Carbon Carbon 6 6 12
C13* 6 7 13
C14** 6 8 14
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Slide 6
Chemistry 101
- EXAMPLE - Stable Label Drug
Ethanol
Mass = 46
Ethanol
Mass = 49
• Physical chemical properties d0-ethanol = d3-ethanol
• The only instrument/test that can distinguish between d0-ethanol and
d3-ethanol is a mass spectrometer
C C
H
H
H
H
H
OH C C
H
H
H
H
H
OH
H
H
H
D
D
D
d0-ethanol d3-ethanol
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Chemistry 101
- Stable Isotopes of Propylene Glycol (PG)
H C C C H
H H H
OH OH H
C3H8O2
Atomic mass = 76
H 13C 13C 13C H
H H H
OH OH H 13C3H8O2
Atomic mass = 79 Carbon Heavy PG
D 13C 13C 13C H
D D H
OH OH H
13C3H5D3O2
Atomic mass = 82 Analytical Internal Standard
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Slide 8
Chemistry 101
- Mass Spectometer in Action
+
+
+
= (m - 2) / z
= m/z that we want
= (m + 2) / z +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Method Summary
Measuring PG in Human Plasma
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
PG LLOQ - 100 ng/mL in Ultrapure Water
Sample Name: "52 010 ZZ41511-01 STD B 1 1" Sample ID: "10" File: "ZZ41511-01-RUN-052-V01.wiff"Peak Name: "Propylene Gl" Mass(es): "285.100/163.200 Da"Comment: "none" Annotation: ""
Sample Index: 10
Sample Type: Standard
Concentration: 100. ng/mL
Calculated Conc: 100. ng/mL
Acq. Date: 8/18/2014
Acq. Time: 4:39:48 PM
Modified: No
Proc. Algorithm: Specify Parameters - MQ III
Noise Percentage: 80
Base. Sub. Window: 1.00 min
Peak-Split. Factor: 2
Report Largest Peak: No
Min. Peak Height: 300.00 cps
Min. Peak Width: 0.00 sec
Smoothing Width: 3 points
RT Window: 30.0 sec
Expected RT: 1.17 min
Use Relative RT: No
Int. Type: Base To Base
Retention Time: 1.10 min
Area: 8045 counts
Height: 4512 cps
Start Time: 1.07 min
End Time: 1.17 min
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 1.1 1.2 1.3 1.4 1.5Time, min
0
100
200
300
400
500
600
700
800
900
1000
1100
1200
1300
1400
1500
1600
1700
1800
1900
2000
2100
2200
2300
2400
2500
2600
2700
2800
2900
3000
3100
3200
3300
3400
3500
3600
3700
3800
3900
4000
4100
4200
4300
4400
4500
4600
Inte
ns
ity
, c
ps
tR: 1.1 min Area: 8045 counts
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
PG Calibration Curve: 100 – 10,000 ng/mL
ZZ41511-01-PRO-V01-Presentation.rdb (Propylene Gl): "Linear" Regression ("1 / (x * x)" weighting): y = 0.000645 x + 0.00757 (r = 0.9997)
0.0 1000.0 2000.0 3000.0 4000.0 5000.0 6000.0 7000.0 8000.0 9000.0 1.0e4Analyte Conc. / IS Conc.
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.4
An
aly
te A
rea
/ I
S A
rea
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
PG Concentrations in Human Plasma
n = 39 plasma lots
10
100
1000
10000
0 5 10 15 20 25 30 35 40
PG
Co
nce
ntr
atio
n (
ng
/ml)
Plasma Lot
Concentrations PG = 40 – 4000 ng/ml
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
13C3-PG Human Plasma Blank
Sample Name: "9 020 ZZ43723-01 Blank 1" Sample ID: "20" File: "ZZ43723-01-RUN-009-V02.wiff"Peak Name: "13C3 Propylene Glycol" Mass(es): "288.200/166.200 Da"Comment: "none" Annotation: ""
Sample Index: 20
Sample Type: Unknown
Concentration: N/A
Calculated Conc: No Intercept
Acq. Date: 8/22/2014
Acq. Time: 12:12:39 PM
Modified: No
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 1.1 1.2 1.3 1.4 1.5Time, min
0
50
100
150
200
250
300
350
400
450
500
550
600
650
700
750
800
850
900
950
1000
1050
1100
1150
1200
1250
1300
1350
1400
1450
1500
1550
1600
1650
1700
1750
1800
1850
1900
1950
2000
Inte
ns
ity
, c
ps
Unlike PG there was no 13C3-PG in human plasma!
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
13C3-PG LLOQ - 5.00 ng/mL in Plasma
Sample Name: "9 010 ZZ43723-01 STD B 1 1" Sample ID: "10" File: "ZZ43723-01-RUN-009-V02.wiff"Peak Name: "13C3 Propylene Glycol" Mass(es): "288.200/166.200 Da"Comment: "none" Annotation: ""
Sample Index: 10
Sample Type: Standard
Concentration: 5.00 ng/mL
Calculated Conc: 4.76 ng/mL
Acq. Date: 8/22/2014
Acq. Time: 11:54:22 AM
Modified: No
Proc. Algorithm: Specify Parameters - MQ III
Noise Percentage: 50
Base. Sub. Window: 1.00 min
Peak-Split. Factor: 2
Report Largest Peak: No
Min. Peak Height: 100.00 cps
Min. Peak Width: 0.00 sec
Smoothing Width: 3 points
RT Window: 30.0 sec
Expected RT: 1.22 min
Use Relative RT: No
Int. Type: Base To Base
Retention Time: 1.23 min
Area: 3387 counts
Height: 1611 cps
Start Time: 1.20 min
End Time: 1.29 min
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 1.1 1.2 1.3 1.4 1.5Time, min
0
50
100
150
200
250
300
350
400
450
500
550
600
650
700
750
800
850
900
950
1000
1050
1100
1150
1200
1250
1300
1350
1400
1450
1500
1550
1600
1650
1700
1750
1800
1850
1900
1950
2000
Inte
ns
ity
, c
ps
tR: 1.2 min Area: 3387 counts
Observation: • PG LLOQ = 100 ng/ml • 13C3–PG LLOQ = 5 ng/ml • This is a big peak at the LLOQ
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
13C3-PG Calibration Curve 5 – 1000 ng/mL
ZZ43723-01-13C-009-V01-Presentation1.rdb (13C3 Propylene Glycol): "Linear" Regression ("1 / (x * x)" weighting): y = 0.0125 x + -2.08e-015 (r = 0.9993)
0 50 100 150 200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 1000Analyte Conc. / IS Conc.
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
8.5
9.0
9.5
10.0
10.5
11.0
11.5
12.0
12.5
13.0
An
aly
te A
rea
/ I
S A
rea
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
The power of stable isotopes in human studies
APPLIED SCIENCE
Not radioactive
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Second Hand Exposure to eCigarettes
• eCigarette filled with 13C3-PG solvent
• Only source of 13C3-PG in the world If any 13C3-PG shows up in this
person’s blood then it had to come from the eCigarette
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Pilot eCigarette 13C3-PG Study:
- Study Product
•
•
98.2% carbon heavy PG
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Pilot eCigarette 13C3-PG Study:
- Study Subjects
• Healthy males
• 26 – 37 years of age
All Subjects
• 6-month product use history, daily product use for 30 days prior to the test visit
• No other nicotine products for the 14 days prior to the test visit
• 12 hour abstention prior to test visit product administration
Vapers
(n = 3)
• No nicotine product use for 14 days prior to the test visit
• Avoid environmental exposure to nicotine for 48 hours prior to the test visit
• USED TO TEST FOR SECOND HAND EXPOSURE
Non-Vapers
(n = 3)
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Pilot eCigarette 13C3-PG Study:
- Study Design
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Estimated exposure by weight of vaping solution
Subject C13C Propylene Glycol (98.2%) Nicotine
(1.8%)
1 239.4 mg 4.39 mg
2* 89.5 mg 1.64 mg
3 237.7 mg 4.36 mg
*Suspected device failure – the subject experienced difficulty activating the device during some of the inhalations.
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Nicotine Plasma Concentrations
Nicotine Cmax from a single conventional cigarette = 15 – 20 ng/ml
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Unlabeled PG Plasma Concentrations
MEAL
Observation: All of these subjects had PG concentrations at the low end of the PG plasma continuum.
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
13C3-PG Plasma Concentrations
– Vaping Subjects
MEAL
Observation: Dosed: 13C3-PG / nicotine = 50 Cmax: 13C3-PG /nicotine > 150 The lung absorption of PG is 3X greater than that of nicotine
Half-life PG = 2 hrs. It would be impossible to calculate this without dosing a stable isotope.
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Second Hand Exposure to eCigarettes
• eCigarette filled with 98.2% 13C3-PG
• Only source of 13C3-PG in the world If any 13C3-PG shows up in this
person’s blood then it had to come from the eCigarette
How much 13C3-PG showed up in this person’s blood?
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
13C3-PG Plasma Concentrations
- Non-Vaping Subjects
Subject 4 5 6
Time (Minutes) 0 60 120 180 240 300 360 420 480
1 3 C
3 P
r o p y l e
n e G
l y c o l C
o n c e n t r a t i o
n
( n g / m
L )
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
LLOQ = 5 ng/ml
No quantifiable concentrations were observed!
Sample Name: "9 010 ZZ43723-01 STD B 1 1" Sample ID: "10" File: "ZZ43723-01-RUN-009-V02.wiff"Peak Name: "13C3 Propylene Glycol" Mass(es): "288.200/166.200 Da"Comment: "none" Annotation: ""
Sample Index: 10
Sample Type: Standard
Concentration: 5.00 ng/mL
Calculated Conc: 4.76 ng/mL
Acq. Date: 8/22/2014
Acq. Time: 11:54:22 AM
Modified: No
Proc. Algorithm: Specify Parameters - MQ III
Noise Percentage: 50
Base. Sub. Window: 1.00 min
Peak-Split. Factor: 2
Report Largest Peak: No
Min. Peak Height: 100.00 cps
Min. Peak Width: 0.00 sec
Smoothing Width: 3 points
RT Window: 30.0 sec
Expected RT: 1.22 min
Use Relative RT: No
Int. Type: Base To Base
Retention Time: 1.23 min
Area: 3387 counts
Height: 1611 cps
Start Time: 1.20 min
End Time: 1.29 min
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 1.1 1.2 1.3 1.4 1.5Time, min
0
50
100
150
200
250
300
350
400
450
500
550
600
650
700
750
800
850
900
950
1000
1050
1100
1150
1200
1250
1300
1350
1400
1450
1500
1550
1600
1650
1700
1750
1800
1850
1900
1950
2000
Inte
ns
ity
, c
ps
13C3-PG LLOQ Chromatogram
LOD is 0.2 ng/ml Were any 13C3-PG
samples above the LOD?
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
13C3-PG Extrapolated Plasma Concentrations below
LLOQ / above LOD – Non-Vaping Subjects
LLOQ = 5 ng/ml
Plasma Concentrations were 5000 X less than
that of Vapers!
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Conclusions
2014
_ST
72_F
arm
en.p
dfC
ongr
ess2
014
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A